In contrast, injecting Aβ-specific CD4+ TH1 and TH17 Teff cells into the brains of APP/PS1 mice has been shown to exacerbate Aβ burden, microgliosis, neuroinflammation, and cognitive impairment [224]. This evidence concerns the gene APP and Cognitive impairment.